[Pathology caused by antibiotics. V. Hepatic lesions. Interference with hepatic production of bilirubin and induction of the enzyme systems of the hepatocytes].
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001663:Bilirubin / Q000096:biosynthesis*; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D006118:Griseofulvin / Q000009:adverse effects; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D009675:Novobiocin / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D009675:Novobiocin; D006118:Griseofulvin; D001663:Bilirubin; D012293:Rifampin
Patologia da antibiotici. v) Le lesioni epatiche. Interferenza con la elaborazione epatica della bilirubina ed induzione sui sistemi enzimatici degli epatociti.